1. Home
  2. MFM vs PROF Comparison

MFM vs PROF Comparison

Compare MFM & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Municipal Income Trust

MFM

MFS Municipal Income Trust

HOLD

Current Price

$5.42

Market Cap

223.2M

Sector

Finance

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.63

Market Cap

199.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFM
PROF
Founded
1986
N/A
Country
United States
Canada
Employees
N/A
142
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.2M
199.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MFM
PROF
Price
$5.42
$6.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$11.00
AVG Volume (30 Days)
108.1K
101.4K
Earning Date
01-01-0001
11-13-2025
Dividend Yield
4.08%
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
N/A
$14,297,000.00
Revenue This Year
N/A
$64.23
Revenue Next Year
N/A
$113.06
P/E Ratio
$176.67
N/A
Revenue Growth
N/A
67.94
52 Week Low
$4.37
$3.76
52 Week High
$5.48
$8.36

Technical Indicators

Market Signals
Indicator
MFM
PROF
Relative Strength Index (RSI) 55.77 57.49
Support Level $5.31 $6.09
Resistance Level $5.47 $7.04
Average True Range (ATR) 0.07 0.42
MACD 0.01 0.02
Stochastic Oscillator 63.64 70.27

Price Performance

Historical Comparison
MFM
PROF

About MFM MFS Municipal Income Trust

MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: